A A Suzdal'tsev

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
This milticentre randomized clinical study of the efficiency of remaxol infusion solution (hepatoprotective medicine for chronic liver dysfunction) included 494 patients with chronic hepatitis B and C. 294 of them staying in 7 clinics were given remaxol and 200 ones received placebo. Randomization was achieved by the envelope method. A detailed description(More)
PURPOSE OF THE STUDY clarify the use in the treatment of CHC patients with cytopenia alternative treatment regimens, including leukocyte interferon alpha-alfaferon with ribavirin in combination with immuno-oriented roncoleukin with contraindications to the use of recombinant interferon alpha. MATERIALS AND METHODS CHC patients with genotype 1b and high(More)
  • 1